Sickle cell disease (SCD) is a devastating medical condition causing pain, fatigue, and early mortality. Join host, Geoff Wall, as he evaluates a new gene therapy via CRISPR that may cure SCD.
 
The GameChanger
CRISPR is a new method to develop targeted gene editing treatments. Lovo-cel is the first FDA-approved therapy and may treat sickle cell disease (SCD) - for only $2 million.
 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
 
Reference
FDA Approval. https://www.fda.gov/vaccines-blood-biologics/lyfgenia.

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss what CRISPR is and how it can be used to treat diseases
2. Describe the use of lovotibeglogene autotemcel (lovo-cel) for sickle cell disease and its safety and efficacy data

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-031-H01-P
Initial release date: 1/8/2024
Expiration date: 1/8/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram